glutamic acid has been researched along with natriuretic peptide, c-type in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tian, M; Yang, XL | 1 |
| Davydova, J; Egbert, JR; Jaffe, LA; Potter, LR; Robinson, JW; Schmidt, H | 1 |
2 other study(ies) available for glutamic acid and natriuretic peptide, c-type
| Article | Year |
|---|---|
C-type natriuretic peptide modulates glutamate receptors on cultured rat retinal amacrine cells.
Topics: Amacrine Cells; Animals; Animals, Newborn; Benzodiazepines; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Immunohistochemistry; Isoenzymes; Membrane Potentials; N-Methylaspartate; Natriuretic Agents; Natriuretic Peptide, C-Type; Patch-Clamp Techniques; Polysaccharides; Rats; Receptors, Glutamate; Retina; Syntaxin 1 | 2006 |
Dephosphorylation is the mechanism of fibroblast growth factor inhibition of guanylyl cyclase-B.
Topics: Animals; Chondrocytes; Cyclic GMP; Disease Models, Animal; Dwarfism; Glutamic Acid; Humans; Natriuretic Peptide, C-Type; Phosphorylation; Rats; Receptor, Fibroblast Growth Factor, Type 3; Receptors, Atrial Natriuretic Factor; Signal Transduction | 2017 |